Biomaterials, 2014 · DOI: 10.1016/j.biomaterials.2014.05.084 · Published: September 1, 2014
Microelectrode technology holds promise for neuroscience and rehabilitation, but its long-term performance is hindered by the neuroinflammatory response. This study aims to differentiate the roles of blood-derived macrophages and resident microglia in this response, which is crucial for developing effective therapeutic strategies to improve microelectrode performance. To distinguish between the roles of infiltrating blood-derived cells and resident microglia, the researchers used chimera mice with cyan fluorescent protein (CFP) labeled blood cells. This allowed them to track the infiltration of blood-derived cells and independently investigate the contributions of microglia and macrophages to neuroinflammation after microelectrode implantation. The study found that blood-borne macrophages, not resident microglia, dominated the infiltrating cell population after microelectrode implantation. Importantly, there was a correlation between increased populations of blood-derived cells, specifically macrophages, and neuron loss at the microelectrode-tissue interface.
Targeting infiltrating macrophages, rather than microglia, could be a more effective therapeutic strategy for mitigating neuroinflammation and improving the longevity of microelectrode function.
Developing biomaterials that minimize macrophage infiltration or modulate macrophage activity could enhance the biocompatibility of intracortical implants.
Local drug delivery strategies that specifically target macrophages at the microelectrode-tissue interface could reduce neurodegeneration and improve recording stability.